Approval · Notice of Compliance 20713 · 2018
SYNAGIS: Notice of Compliance 20713
Issued April 9, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20713
- Date
- April 9, 2018
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNAGIS | Not yet assigned | — |
Medicinal ingredients
- PALIVIZUMAB 100 MG per ML